Change in Director(s)

Date: 24th August, 2026 Listing Department, National Stock Exchange of India Limited Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 NSE Symbol: BALAXI Subject: Re-appointment of Ms. Akshita Ostwal (DIN: 10026552) as an Independent Director of the Company. Dear Sir/Madam, Further to our letter dated 28th May, 2026, we write to advise that the Members of the Company at the 83rd Annual General Meeting held today i.e., 24th August, 2026, have approved the re-appointment of Ms. Akshita Ostwal (DIN: 10026552) as an Independent Director of the Company for a second term of five consecutive years with effect from September 05, 2026. Brief profile and other details of Ms. Akshita Ostwal, as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular dated 30th January, 2026, are given in the Annexure - A. To the best of our knowledge & information, and as also confirmed by Ms. Akshita Ostwal, she has not been debarred from holding the office of Director by virtue of an order of the SEBI or any other authority. The aforesaid information will also be available on the Company’s website at www.balaxipharma.in This is for your information and records. Yours faithfully, For Balaxi Pharmaceuticals Limited Aman Purohit (Company Secretary and Compliance Officer) Membership No.: A59345 Encl: As above ANNEXURE - A Brief profile and other details of Ms. Akshita Ostwal, as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular dated 30th January, 2026: Sl. Particulars Remarks 1. R eason for change viz. Re-appointment of Ms. Akshita Ostwal as an appointment, I ndependent Director of the Company, for a second re-appointment, term of five consecutive years commencing from resignation, removal, September 05, 2026 to September 04, 2031 (both days death or otherwise; inclusive). 2. D ate of Appointment/ re-appointment/cessation Date of re-appointment: September 05, 2026 (as applicable) & term of appointment/ Term of re-appointment: September 05, 2026 to re-appointment September 04, 2031 3. B rief Profile Akshita Ostwal is the founder of Akshita Surana & Associates, a peer-reviewed firm of practicing company secretaries. With over ten years of experience in corporate laws and IPR laws advisory, consulting, and litigation, she has steadily built a reputation as a reliable and knowledgeable professional. Akshita is fellow practicing company secretary, a registered trademark agent, and she holds a Master's degree in Law. Additionally, she is also a member of the Chartered Governance Institute of UK & Ireland. 4. D isclosure of Not applicable relationship between the Directors (in case of appointment of a Director) 5. I nformation as required Ms. Akshita Ostwal is not debarred from holding office under Circular No. of a Director by virtue of any SEBI order or any other NSE/CML/2O18/02 such authority. dated June 20, 2018 issued by NSE.